International: Congress focuses on FDA inspections of foreign drug facilities

被引：0

|

作者：

Van, Arnum, Patricia

机构：

来源：

Pharmaceutical Technology | 2007年 / 31卷 / 11期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[21] Foreign policy and congress: An international relations perspective.
Peake, JS
ARMED FORCES & SOCIETY, 2002, 28 (02) : 353 - 356
[22] Foreign policy and Congress: An international relations perspective.
Michelson, MR
AMERICAN POLITICAL SCIENCE REVIEW, 2001, 95 (02) : 471 - 472
[23] UNITED-STATES DRUG REGULATION - CONGRESS FINDS FDA WANTING
BUDIANSKY, S
NATURE, 1982, 298 (5875) : 597 - 598
[24] Helsinki discords: FDA, ethics, and international drug trials
Kimmelman, Jonathan
Weijer, Charles
Meslin, Eric M.
LANCET, 2009, 373 (9657): : 13 - 14
[25] KREBIOZEN - FDA, NIH STILL ON TRAIL OF ANTICANCER DRUG - AND CONGRESS ON TRAIL OF AGENCIES
LANGER, E
SCIENCE, 1963, 141 (358) : 1021 - &
[26] The Fifth International Congress on Drug Therapy in HIV Infection
Nadler, JP
INFECTIONS IN MEDICINE, 2001, 18 (01) : 20 - +
[27] CLOSURE THREAT AT FDA LABORATORIES - DRUG-TESTING FACILITIES GIVEN LOW PRIORITY
不详
NATURE, 1981, 294 (5837) : 101 - 101
[28] As Use of Foreign Drug Trials Grows, FDA Oversight May Not Be Keeping Up
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (08): : 843 - 844
[29] FDA Focuses on Drug Appearance and Attributes: FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence
Wechsler, Jill
Pharmaceutical Technology, 2014, 38 (02) : 14 - 15
[30] FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 Levels
Cuddy, Emily
Lu, Yun Peng
Ridley, David B.
HEALTH AFFAIRS, 2023, 42 (12) : 1758 - 1766

← 1 2 3 4 5 →